TDAM USA’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $5.39M | Buy |
86,453
+1,479
| +2% | +$86.8K | 0.33% | 86 |
|
|
2021
Q3 | $5.03M | Buy |
84,974
+5,806
| +7% | +$382K | 0.33% | 92 |
|
|
2021
Q2 | $5.37M | Buy |
79,168
+33
| +0% | +$2.15K | 0.33% | 90 |
|
|
2021
Q1 | $5M | Buy |
79,135
+42
| +0.1% | +$2.61K | 0.3% | 98 |
|
|
2020
Q4 | $4.91M | Buy |
79,093
+11,240
| +17% | +$691K | 0.31% | 94 |
|
|
2020
Q3 | $4.09M | Sell |
67,853
-14,852
| -18% | -$894K | 0.28% | 100 |
|
|
2020
Q2 | $4.78M | Buy |
82,705
+1,624
| +2% | +$97.1K | 0.35% | 91 |
|
|
2020
Q1 | $4.52M | Buy |
81,081
+1,649
| +2% | +$101K | 0.38% | 86 |
|
|
2019
Q4 | $5.1M | Buy |
79,432
+9,813
| +14% | +$562K | 0.33% | 100 |
|
|
2019
Q3 | $3.53M | Buy |
69,619
+670
| +1% | +$31.5K | 0.25% | 114 |
|
|
2019
Q2 | $3.13M | Buy |
68,949
+1,555
| +2% | +$72.4K | 0.22% | 111 |
|
|
2019
Q1 | $3.21M | Sell |
67,394
-1,370
| -2% | -$68.2K | 0.23% | 104 |
|
|
2018
Q4 | $3.57M | Sell |
68,764
-26,446
| -28% | -$1.42M | 0.26% | 102 |
|
|
2018
Q3 | $5.74M | Sell |
95,210
-10
| -0% | -$593 | 0.35% | 94 |
|
|
2018
Q2 | $5.27M | Sell |
95,220
-3,626
| -4% | -$196K | 0.33% | 92 |
|
|
2018
Q1 | $6.25M | Sell |
98,846
-1,394
| -1% | -$89.7K | 0.38% | 88 |
|
|
2017
Q4 | $6.14M | Sell |
100,240
-1,989
| -2% | -$124K | 0.35% | 86 |
|
|
2017
Q3 | $6.52M | Sell |
102,229
-924
| -0.9% | -$54K | 0.38% | 84 |
|
|
2017
Q2 | $5.76M | Sell |
103,153
-1,090
| -1% | -$59.3K | 0.3% | 99 |
|
|
2017
Q1 | $5.67M | Buy |
104,243
+8,963
| +9% | +$492K | 0.29% | 97 |
|
|
2016
Q4 | $5.57M | Sell |
95,280
-12,962
| -12% | -$709K | 0.29% | 95 |
|
|
2016
Q3 | $5.84M | Buy |
108,242
+1,263
| +1% | +$81.1K | 0.29% | 99 |
|
|
2016
Q2 | $7.87M | Sell |
106,979
-2,239
| -2% | -$158K | 0.39% | 85 |
|
|
2016
Q1 | $6.98M | Sell |
109,218
-1,973
| -2% | -$124K | 0.34% | 91 |
|
|
2015
Q4 | $7.65M | Sell |
111,191
-4,488
| -4% | -$297K | 0.37% | 86 |
|
|
2015
Q3 | $6.85M | Sell |
115,679
-9,204
| -7% | -$584K | 0.35% | 92 |
|
|
2015
Q2 | $8.31M | Sell |
124,883
-5,881
| -4% | -$388K | 0.38% | 88 |
|
|
2015
Q1 | $8.43M | Sell |
130,764
-5,592
| -4% | -$350K | 0.34% | 93 |
|
|
2014
Q4 | $8.05M | Sell |
136,356
-6,643
| -5% | -$375K | 0.34% | 97 |
|
|
2014
Q3 | $7.32M | Sell |
142,999
-14,748
| -9% | -$737K | 0.32% | 102 |
|
|
2014
Q2 | $7.65M | Sell |
157,747
-7,846
| -5% | -$387K | 0.32% | 102 |
|
|
2014
Q1 | $8.6M | Sell |
165,593
-7,979
| -5% | -$425K | 0.37% | 92 |
|
|
2013
Q4 | $9.22M | Sell |
173,572
-160,274
| -48% | -$8.16M | 0.4% | 80 |
|
|
2013
Q3 | $15.4M | Sell |
333,846
-18,238
| -5% | -$801K | 0.73% | 49 |
|
|
2013
Q2 | $16.2M | Buy |
+352,084
| New | +$15.3M | 0.74% | 47 |
|
Other funds holding BMY
TDAM USA's BMY Position: Q4 2021 in Review
TDAM USA increased its Bristol-Myers Squibb (BMY) stake by 1.7% in Q4 2021, buying an estimated $86.8K and bringing the position to 86,453 shares worth $5.39M. The position accounts for 0.33% of the portfolio, ranked #86.
TDAM USA first reported a position in BMY in Q2 2013 and has held it in 35 quarters since. The position peaked at $16.2M in Q2 2013. 2,445 funds tracked by Wall St. Rank hold BMY as of Q4 2021.
- TDAM USA held 86,453 shares of Bristol-Myers Squibb worth $5.39M as of Q4 2021.
- TDAM USA bought 1,479 Bristol-Myers Squibb shares in Q4 2021, an estimated $86.8K.
- Bristol-Myers Squibb made up 0.33% of TDAM USA's portfolio in Q4 2021, its #86 holding.
- TDAM USA first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 35 quarters since.
- TDAM USA's Bristol-Myers Squibb position peaked at $16.2M in Q2 2013.
- 2,445 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2021.
Based on TDAM USA's 13F filing for Q4 2021, filed 10 Feb 2022.